The Federal Court of Australia held that Bristol-Myers Squibb Company (BMS) is not the exclusive licensee of a patent relating to aripiprazole under the terms of the licence granted to it by Otsuka Pharmaceutical Co Ltd (Otsuka). As a result, BMS...
By: Freehills Patent Attorneys
By: Freehills Patent Attorneys